1. "Gynecologic Medicine Service"
Formats
  1. Journal Article (1087)
  2. Meeting Abstract (890)
  3. Review (52)
  4. Book Section (46)
  5. Editorial (35)
  6. Guidelines (21)
  7. Correspondence (9)
  8. Miscellaneous (3)
  9. Research Letter (2)
  10. Book Whole (1)
Groups
  1. Gynecologic Medicine Service (2146)
  2. Solid Tumor Oncology Division (2146)
  3. Department of Medicine (2142)
  4. Gynecology Disease Management Team (1846)
  5. GDMT, Medicine (1828)
  6. Surgery (594)

More Groups

People
  1. Carol Aghajanian (607)
  2. Martee Hensley (289)
  3. Nadeem Abu-Rustum (288)
  4. Roisin O'Cearbhaill (271)
  5. Vicky Makker (263)
  6. Paul Sabbatini (262)

More People

Years
  1. 2025 (41)
  2. 2024 (167)
  3. 2023 (171)
  4. 2022 (209)
  5. 2021 (163)
  6. 2020 (203)

More Years

Publications
  1. Journal of Clinical Oncology (450)
  2. Gynecologic Oncology (418)
  3. International Journal of Gynecological Cancer (154)
  4. Annals of Oncology (116)
  5. Clinical Cancer Research (67)
  6. Cancer Research (55)

More Publications

Publishers
  1. Elsevier Inc. (542)
  2. American Society of Clinical Oncology (489)
  3. Lippincott Williams & Wilkins (181)
  4. American Association for Cancer Research (168)
  5. Oxford University Press (143)
  6. Nature Publishing Group (86)

More Publishers

Results (2146)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Bioluminescence evaluation of efficacy of oncolytic treatment with Newcastle disease virus (NDV) in malignant pleural mesothelioma
    Meeting Abstract

    Silberhumer, G.; Brader, P.; Wong, J.; Zamarin, D.; Serganova, I.; Blasberg, R.; Palese, P.; Fong, Y.
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save
  • Evaluation of the role of aromatase inhibitors (AIs) in the treatment of uterine leiomyosarcoma (uLMS)
    Meeting Abstract

    O'Cearbhaill, R.; Zhou, Q.; Iasonos, A.; Soslow, R. A.; Leitao, M. M. Jr; Aghajanian, C. A.; Hensley, M. L.
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save
  • Geriatric medication management: Evaluation of pharmacist interventions and potentially inappropriate medication (PIM) use in older (≥65 years) cancer patients
    Meeting Abstract

    Lichtman, S. M.; Boparai, M. K.
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save
  • A phase II study of intravenous (IV) and intraperitoneal (IP) paclitaxel, IP cisplatin, and IV bevacizumab as first-line chemotherapy for optimal stage II or III ovarian, primary peritoneal, and fallopian tube cancer
    Meeting Abstract

    Konner, J. A.; Grabon, D.; Pezzulli, S.; Iasonos, A.; Sabbatini, P.; Hensley, M.; Bell-McGuinn, K.; Tew, W.; Spriggs, D.; Aghajanian, C.
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save
  • First-in-human phase I study of the novel structure proteasome inhibitor NPI-0052
    Meeting Abstract

    Hamlin, P. A.; Aghajanian, C.; Younes, A.; Hong, D. S.; Palladino, M. A.; Longenecker, A. M.; Lloyd, G. K.; Hannah, A. L.; Spear, M. A.; Kurzrock, R.
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save
  • Geriatric assessment of older adults with cancer: Baseline data from a 500 patient multicenter study
    Meeting Abstract

    Hurria, A.; Mohile, S.; Lichtman, S.; Owusu, C.; Klepin, H.; Gross, C.; Hansen, K.; Klapper, S.; Togawa, K.; Tew, W.
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save
  • Eribulin mesylate (halichondrin B Analog E7389) in platinum-resistant epithelial ovarian cancer (PR-EOC): A CTEP-sponsored phase II study
    Meeting Abstract

    Hensley, M. L.; Kravetz, S.; Sima, C.; Tew, W.; Pereira, L.; Sabbatini, P.; Whalen, C.; Aghajanian, C. A.; Zarwan, C.; Berlin, S.
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save
  • Incidence of adnexal and lymph node metastases in endometrial stromal sarcoma
    Meeting Abstract

    dos Santos, L.; Garg, K.; Diaz, J. P.; Soslow, R. A.; Hensley, M. L.; Alektiar, K. M.; Barakat, R. R.; Leitao, M. M. Jr
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save
  • Dose-dense (DD) cyclophosphamide, methotrexate, and fluorouracil (CMF) at 14-day intervals: A pilot study of every 14- and 10-11-day dosing intervals for women with early-stage breast cancer
    Meeting Abstract

    Drullinsky, P.; Fornier, M. N.; Sugarman, S.; D'Andrea, G.; Troso-Sandoval, T.; Seidman, A. D.; Yuan, J.; Patil, S.; Norton, L.; Hudis, C.
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save
  • A phase II evaluation of bevacizumab in the treatment of recurrent or persistent endometrial cancer: A Gynecologic Oncology Group (GOG) study
    Meeting Abstract

    Aghajanian, C.; Sill, M. W.; Darcy, K.; Greer, B.; McMeekin, D. S.; Rose, P. G.; Rotmensch, J.; Barnes, M. N.; Hanjani, P.; Leslie, K.
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save